Physician Search

Consuelo Wilkins, MD, MSCI, Senior Vice President for Health Equity and Inclusive Excellence for Vanderbilt University Medical Center (VUMC) and Senior Associate Dean for Health Equity and Inclusive Excellence for Vanderbilt University School of Medicine, always knew she wanted to be a physician. "Health equity was built into everything I did, even if I didn’t know it or recognize it at the time," Wilkins said. "I have always learned and believed that people are the same — everyone deserves to be healthy, and everyone should have the best opportunities to take care of themselves and their families." Click below to learn more about health equity initiatives.

https://momentum.vicc.org/2021/09/everyone-deserves-to-be-healthy/

Vanderbilt was the lead site for an NIH-funded, phase 2, multicenter influenza vaccine study in pediatric allogeneic hematopoietic stem cell transplant (HCT) recipients that may lead to a change in the current flu vaccine recommendations in this vulnerable population. Natasha Halasa, MD, MPH and colleagues recently published in the New England Journal of Medicine, that two doses of high-dose trivalent flu vaccine resulted in higher amounts of influenza-specific antibodies than two doses of standard dose quadrivalent vaccine.

https://news.vumc.org/2023/03/02/high-dose-flu-vaccine-beneficial-for-pediatric-stem-cell-transplant-patients/

Filter By:
Search by Keyword:

Displaying 281 - 287 of 287

Renal Tumors Classification, Biology, and Banking Study

Multiple Cancer Types

Disease Sites: Pediatrics, Wilms / Other Kidney (Pediatrics)

Phase: N/A

Investigator: Benedetti, Daniel

NCTID: NCT00898365

Protocol No: COGAREN03B2

Storage and Research Use of Human Biospecimens from Melanoma Patients and Clinical Testing for the Assignment of Therapy

Melanoma

Disease Sites: Melanoma

Phase: N/A

Investigator: Johnson, Douglas

NCTID: NCT01205815

Protocol No: VICCMEL09109

Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

Hematologic

Disease Sites: Hematologic

Phase: N/A

Investigator: Kassim, Adetola

NCTID: NCT04920474

Protocol No: NMDPCTT0346

An Open Label, Expanded Access Protocol using 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy in Patients with Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma

Multiple Cancer Types

Disease Sites: Neuroblastoma (Pediatrics), Pediatric Solid Tumors

Phase: N/A

Investigator: Kitko, Carrie

NCTID: NCT01590680

Protocol No: VICCPED1249

Neuroblastoma Biology Studies

Multiple Cancer Types

Disease Sites: Neuroblastoma (Pediatrics), Pediatrics

Phase: N/A

Investigator: Benedetti, Daniel

NCTID: NCT00256763

Protocol No: CCGANBL00B1

Preserving Fertility After Colorectal Cancer: The PREFACE Study

Multiple Cancer Types

Disease Sites: Colon, Rectal

Phase: N/A

Investigator: Holowatyj, Andreana

NCTID: NCT05239338

Protocol No: VICCGI2186

Novel Gastrointestinal Cancer Markers in Tissue and Biofluids

Gastrointestinal

Disease Sites: Gastrointestinal

Phase: N/A

Investigator: Beauchamp, Robert

NCTID: NCT00899626

Protocol No: VICCGI0283